Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study
- PMID: 16777887
- PMCID: PMC1479641
- DOI: 10.1136/bmj.332.7555.1435
Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study
Abstract
Problem: Bacteraemia in dialysis units accounts for major morbidity, mortality, and antibiotic usage. Risk is much greater when lines rather than fistulas are used for haemodialysis. Surveillance is critical for infection control, but no standardised surveillance scheme exists in the United Kingdom.
Design: Prospective study in a London dialysis unit of the implementation and applicability of a dialysis associated bacteraemia surveillance scheme developed in the United States and its effect on bacteraemia, antibiotic usage, and admission.
Setting: Hammersmith Hospital dialysis unit, London, where 112 outpatients receive dialysis three times weekly. Between June 2002 and December 2004, 3418 patient months of data were collected.
Key measures for improvement: Successful adoption of the scheme and reductions in bacteraemia rates, antibiotic usage, and admission to hospital. Strategy for improvement Embedding the surveillance scheme in the unit's clinical activity.
Effects of change: Raised awareness of bacteraemia prevention, prudent antibiotic prescribing, and the need for improved provision of vascular access. The scheme required two hours a month of consultant time. Significant downward trends were seen in bacteraemia rates and antibiotic usage: mean rate ratios from quarter to quarter 0.90 (95% confidence interval 0.85 to 0.94) and 0.91 (0.87 to 0.96), respectively. The rate of admission to hospital also showed a significant downward trend, with admissions directly connected to access related infection declining more rapidly: mean rate ratio of successive quarters 0.90 (0.84 to 0.96). The overall proportion of patients dialysed through catheters was significantly higher than in US outpatient centres (62.3% v 29.4%, P < 0.01). Study data were successfully used in a business case to improve access provision.
Lessons learnt: Dialysis specific surveillance of bacteraemia is critical to infection control in dialysis units and improving quality of care. Such a scheme could be adopted across the United Kingdom.
Figures
References
-
- A progress report by the Comptroller and Auditor General HC 876 session 2003-4. Improving patient care by reducing the risk of hospital acquired infection. London: UK National Audit Office, 2004;14 July.
-
- Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control 2002;30: 288-95. - PubMed
-
- Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S, Canadian Hospital Epidemiology Committee. Canadian nosocomial infection surveillance program. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 2002;23: 716-20. - PubMed
-
- Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and United States: results from DOPPS. Kidney Int 2002;61: 305-16. - PubMed
-
- Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant 2004;19: 108-20. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials